Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

Nat Immunol. 2020 Nov;21(11):1470. doi: 10.1038/s41590-020-0794-2.

Emma S Winkler^#^{1

2}, Adam L Bailey^#², Natasha M Kafai^{1

2}, Sharmila Nair¹, Broc T McCune¹, Jinsheng Yu³, Julie M Fox¹, Rita E Chen^{1

2}, James T Earnest¹, Shamus P Keeler^{1

4}, Jon H Ritter², Liang-I Kang², Sarah Dort⁵, Annette Robichaud⁵, Richard Head³, Michael J Holtzman^{1

4}, Michael S Diamond^{6

7

8

9}

¹ Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
² Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
³ Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
⁴ Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
⁵ SCIREQ Scientific Respiratory Equipment, Montreal, Quebec, Canada.
⁶ Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
⁷ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
⁸ Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.
⁹ The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA. diamond@wusm.wustl.edu.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.